Small · 2023 · 14 citations · 24 references
MedicineInfectious DiseasesMolecular BiologyEarly DetectionMolecular DiagnosticsVirologyInfectious Disease DetectionInfectious Disease Molecular TestingMolecular ScreeningPathogen DetectionRapid Diagnostic TestsViral DiagnosticsCoronavirus DiagnosticsDetectionEarly ScreeningMicroarray-based DetectionRapid Antigen Detection TestingRapid Antigen TestingRapid Antigen TestsViral Antigen Detection
Abstract Rapid and ultra‐sensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is critical for early screening and management of COVID‐19. Currently, the real‐time reverse transcription polymerase chain reaction (rRT‐PCR) is the primary laboratory method for diagnosing SARS‐CoV‐2. It is not suitable for at‐home COVID‐19 diagnostic test due to the long operating time, specific equipment, and professional procedures. Here an all‐printed photonic crystal (PC) microarray with portable device for at‐home COVID‐19 rapid antigen test is reported. The fluorescence‐enhanced effect of PC amplifies the fluorescence intensity of the labeled probe, achieving detection of nucleocapsid (N‐) protein down to 0.03 pg mL −1 . A portable fluorescence intensity measurement instrument gives the result (negative or positive) by the color of the indicator within 5 s after inserting the reacted PC microarray test card. The N protein in inactivated virus samples (with cycle threshold values of 26.6–40.0) can be detected. The PC microarray provides a general and easy‐to‐use method for the timely monitoring and eventual control of the global coronavirus pandemic.
24
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Jasper Fuk‐Woo Chan, Cyril Chik‐Yan Yip, Kelvin Kai‐Wang To et al. · Journal of Clinical Microbiology · 2020 · 936 citations · Full text